Shire is weighing options for sweetening its multi-billion-dollar, all-stock offer for U.S. biotechnology firm Baxalta Inc. by putting cash into shareholders’ hands sooner, said people familiar with the matter.
WSJ.com: What's News Europe, Wall Street Journal: What's News Europe
Sun, 09/13/2015 - 4:00pm
Shire is weighing options for sweetening its multi-billion-dollar, all-stock offer for U.S. biotechnology firm Baxalta Inc. by putting cash into shareholders’ hands sooner, said people familiar with the matter.